Hercules Technology Growth Capital Inc  

(Public, NYSE:HTGC)   Watch this stock  
Find more results for NASDAQ:HTGC
12.82
+0.07 (0.55%)
May 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 12.58 - 12.84
52 week 12.34 - 16.99
Open 12.75
Vol / Avg. 582,918.00/373,643.00
Mkt cap 930.54M
P/E 11.75
Div/yield 0.31/9.67
EPS 1.09
Shares 72.58M
Beta 1.05
Inst. own 38%
Aug 5, 2015
Q2 2015 Hercules Technology Growth Capital Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 7, 2015
Hercules Technology Growth Capital Inc Annual Shareholders Meeting - 9:00AM EDT - Add to calendar
May 7, 2015
Q1 2015 Hercules Technology Growth Capital Inc Earnings Call - Webcast
May 7, 2015
Q1 2015 Hercules Technology Growth Capital Inc Earnings Release
Apr 14, 2015
Hercules Technology Growth Capital Inc at Latham & Watkins Emerging Growth Debt, Part II: Insolvency and Related Considerations - Maximizing Enterprise Value
Mar 2, 2015
Q4 2014 Hercules Technology Growth Capital Inc Earnings Call - Webcast
Mar 2, 2015
Q4 2014 Hercules Technology Growth Capital Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 67.46% 49.55%
Operating margin 39.99% 49.94%
EBITD margin - 51.23%
Return on average assets 6.55% 5.65%
Return on average equity 12.05% 10.63%
Employees 65 -
CDP Score - -

Address

400 Hamilton Ave Ste 310
PALO ALTO, CA 94301-1805
United States - Map
+1-650-2893060 (Phone)
+1-650-4739194 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Hercules Technology Growth Capital, Inc. is focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy and renewables technology industries at all stages of development. The Company is an internally managed, non-diversified, closed-end investment company. The Company’s strategy is to evaluate and invest in a broad range of technology-related markets including technology, biotechnology, life science, and energy and renewables technology industries and to offer a full suite of growth capital products. The Company invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. It invests primarily in private companies but also has investments in public companies.

Officers and directors

Manuel A. Henriquez Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jessica T. Baron CPA Chief Financial Officer, Vice President - Finance
Age: 40
Bio & Compensation  - Reuters
Scott Bluestein Chief Investment Officer
Age: 36
Bio & Compensation  - Reuters
Andrew Olson Corporate Controller
Age: 32
Bio & Compensation  - Reuters
Allyn C. Woodward Jr. Lead Independent Director
Age: 74
Bio & Compensation  - Reuters
Robert P. Badavas Independent Director
Age: 62
Bio & Compensation  - Reuters
Thomas J. Fallon Independent Director
Age: 53
Bio & Compensation  - Reuters
Joseph F. Hoffman Independent Director
Age: 66
Bio & Compensation  - Reuters
Susanne D. Lyons Independent Director
Age: 58
Bio & Compensation  - Reuters